Dietary supplements are wildly popular, but large clinical trials and other research by Cancer Center shows many common dietary supplements offer little proven benefit for cancer prevention, and in ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

Adenocarcinoma is the most common type of prostate cancer and affects over 95% of cases. Small-cell carcinoma is an aggressive type of prostate cancer that often spreads quickly. Transitional cell ...

Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health. Alcohol is part of many people’s social lives, ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

When travel writer Rick Steves, 70, switched insurance providers, he visited a new doctor, who suggested Steves undergo a prostate-specific antigen (PSA) test. Steves agreed. “He called me two days ...

Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found. By Roni Caryn Rabin Prostate cancer ...